Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 164 | 186 | +22 |
| Shares | 66.0M | 70.7M | +4.69M (+7.1%) |
| Value | $446.7M | $585.5M | +$138.8M (+31.1%) |
New holders (36)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (14)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Aviva PLC | 386,085 | $2.61M |
| Marshall Wace, LLP | 200,308 | $1.36M |
| HRT Financial LP | 132,366 | $896.0K |
| Squarepoint Ops LLC | 89,336 | $605.0K |
| O'Shaughnessy Asset Management, LLC | 73,599 | $498.0K |
| Advisors Asset Management, Inc. | 43,959 | $297.6K |
| One Wealth Advisors, LLC | 22,008 | $149.0K |
| XTX Topco Ltd | 19,253 | $130.0K |
| Tocqueville Asset Management L.P. | 15,594 | $106.0K |
| IFG Advisory, LLC | 13,795 | $93.0K |
| Credit Agricole S A | 10,000 | $68.0K |
| CoreCap Advisors, LLC | 6,000 | $41.0K |
| Cassady Schiller Wealth Management, LLC | 800 | $5.00K |
| Massmutual Trust Co FSB | 85 | $1.00K |